Valuation Atossa Therapeutics, Inc.

Stocks

Delayed Nasdaq Other stock markets 19:58:29 28/07/2026 +04			5-day change	1st Jan Change
2.400 ^USD	+1.69%		0.00%	-72.88%

05:36pm	Atossa Therapeutics Announces Publication of Novel (Z)-Endoxifen-Related Compounds Demonstrating Potent Anti-Cancer Activity in Er-Positive Breast Cancer	CI
06-29	Atossa Therapeutics, Inc.(NasdaqCM:ATOS) added to Russell Microcap Value Benchmark Index	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	202.6	66.92	110.3	118.8	76.21	20.32	-	-
Change	-	-66.97%	64.77%	7.71%	-35.83%	-73.33%	-	-
Enterprise Value (EV)	202.6	66.92	110.3	118.8	76.21	20.32	20.32	20.32
Change	-	-66.97%	64.77%	7.71%	-35.83%	-73.33%	0%	0%
P/E	-8.89x	-2.52x	-3.67x	-4.72x	-2.19x	-0.54x	-0.68x	0.91x
PBR	1.47x	0.57x	1.22x	1.69x	1.92x	-	-	-
PEG	-	-0.2x	-0.3x	0.3x	-0.1x	-0.07x	0x	-0x
Capitalization / Revenue	-	-	-	-	-	-	-	0.17x
EV / Revenue	-	-	-	-	-	-	-	0.17x
EV / EBITDA	-	-	-	-	-	-	-	-
EV / EBIT	-0x	-0x	-0x	-0x	-0x	-0.53x	-0.52x	0.43x
EV / FCF	-	-	-	-	-	-	-	-
FCF Yield	-	-	-	-	-	-	-	-
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	-2.7	-3.15	-3.6	-3	-4.04	-4.333	-3.463	2.59
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	-	-	-	-	-	-	-	118.7
EBITDA	-	-	-	-	-	-	-	-
EBIT ¹	-20.52	-27.69	-31.38	-27.62	-37.14	-38.09	-39.31	47.54
Net income ¹	-20.61	-26.96	-30.09	-25.5	-34.77	-37.39	-39.31	47.54
Net Debt	-	-	-	-	-	-	-	-
Reference price ²	24.000	7.927	13.200	14.161	8.850	2.360	2.360	2.360
Nbr of stocks (in thousands)	8,442	8,442	8,354	8,387	8,611	8,611	-	-
Announcement Date	28/02/22	22/03/23	01/04/24	25/03/25	25/03/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
ATOSSA THERAPEUTICS, INC.	-0.54x	-	-	-	20.32M
LONZA GROUP AG	32.79x	5.87x	17.42x	1%	47.74B
REVOLUTION MEDICINES, INC.	-23.47x	352.2x	-21.51x	-.--%	39.98B
BEONE MEDICINES AG	48.32x	4.93x	31.87x	-.--%	36.23B
IQVIA HOLDINGS INC.	25.95x	2.85x	12.32x	-.--%	35.59B
CELLTRION, INC.	27.91x	7.98x	19.84x	0.43%	27.91B
MEDPACE HOLDINGS, INC.	33.62x	5.49x	25.05x	-.--%	16.45B
EUROFINS SCIENTIFIC SE	22.1x	1.97x	8.54x	1.19%	13.21B
ICON PUBLIC LIMITED COMPANY	23.86x	1.9x	11.51x	-.--%	12.93B
Average	21.17x	47.90x	13.13x	0.33%	25.56B
Weighted average by Cap.	22.75x	65.23x	12.14x	0.33%